Table 2 Prior therapy Prior therapy, no.... | American Society of Hematology

Table 2

Prior therapy

Prior therapy, no. of pts (%)	N = 47
Cytotoxic chemotherapy	47 (100)
Interferon	3 (6)
Bexarotene	3 (6)
Experimental and other*	3 (6)
Stem-cell transplant†	18 (38)
Radiation Therapy	19 (40)
Median number of prior therapies (range)	3 (1-11)
Median number of prior cytotoxic therapies (range)	2 (1-6)
Prior cytotoxic regimens in 47 patients (no.)	n = 118
CHOP	32
ICE	11
Methotrexate (single agent)	6
CVAD	5
EPOCH	5
Various other regimens	59
Other combination regimens	45
Other single agent regimens	14

Prior therapy, no. of pts (%)	N = 47
Cytotoxic chemotherapy	47 (100)
Interferon	3 (6)
Bexarotene	3 (6)
Experimental and other*	3 (6)
Stem-cell transplant†	18 (38)
Radiation Therapy	19 (40)
Median number of prior therapies (range)	3 (1-11)
Median number of prior cytotoxic therapies (range)	2 (1-6)
Prior cytotoxic regimens in 47 patients (no.)	n = 118
CHOP	32
ICE	11
Methotrexate (single agent)	6
CVAD	5
EPOCH	5
Various other regimens	59
Other combination regimens	45
Other single agent regimens	14

Includes denileukin diftitox, UCN01, pralatrexate, and 506U78.

Includes both patients with ALK-positive anaplastic large T-cell lymphoma.